| 2025-04-03 |
复牌提示：
2025-04-03 11:15:06 停牌，复牌日期 2025-04-03 11:20:06
|
| 2025-03-19 |
详情>>
股本变动：
变动后总股本124.25万股
变动原因 ▼▲
- 原因：
- 1-for-25 reverse stock split of its common stock
|
| 2025-03-19 |
详情>>
拆分方案：
每25.0000合并分成1.0000股
|
| 2025-03-03 |
详情>>
业绩披露：
2024年年报每股收益-2.84美元,归母净利润-1206.72万美元,同比去年增长20.56%
|
| 2024-12-09 |
股东大会：
将于2025-01-15召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Amendment”), in substantially the form attached to the proxy statement as Annex A, to, at the discretion of the Board of Directors of the Company (the “Board”), effect a reverse stock split with respect to the Company’s issued and outstanding common stock, par value $0.00001 per share (“Common Stock”), including stock held by the Company as treasury shares, at a ratio of 1-for-2 to 1-for-240 (the “Range”), with the ratio within such Range (the “Reverse Stock Split Ratio”) to be determined at the discretion of the Board and included in a public announcement (the “Reverse Stock Split Proposal” or “Proposal 1”);
2.To elect five directors, Jatinder Dhaliwal, Katharyn Field, Jaydriane Panis, Judy Su, and Esha Randhawa, each to hold office until our Annual Meeting of Shareholders to be held in 2025 or their respective successor is duly elected and qualified (the “Director Proposal” or “Proposal 2”);
3.To approve an adjournment of the 2025 Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Reverse Stock Split Proposal and/or the Director Proposal (the “Adjournment Proposal” or “Proposal 3”).
|
| 2024-11-14 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-3.34美元,归母净利润-867.71万美元,同比去年增长18.35%
|
| 2024-10-10 |
详情>>
业绩披露：
2023年年报每股收益-12.97美元,归母净利润-1518.95万美元,同比去年增长29.84%
|
| 2024-10-10 |
详情>>
业绩披露：
2022年年报每股收益-18.49美元,归母净利润-2165.07万美元,同比去年增长-79.58%
|
| 2024-08-12 |
详情>>
业绩披露：
2024年中报每股收益-4.24美元,归母净利润-667.07万美元,同比去年增长-43.97%
|
| 2024-06-12 |
股东大会：
将于2024-07-29召开股东大会
会议内容 ▼▲
- 1.To elect the two director nominees named herein to serve as Class III directors for a three-year term expiring at the annual meeting of stockholders in 2027;
2.To ratify the appointment of EisnerAmper LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024;
3.To approve an amendment to our 2022 Equity Incentive Plan (the “2022 Plan”), in substantially the form attached to the proxy statement as Annex A, to increase the number of shares of common stock, par value $0.00001 per share (“Common Stock”) that will be available for awards under the 2022 Plan by 267,799 shares to 500,000 shares (the “2022 Plan Share Increase Proposal” or “Proposal 3”);
4.To approve an amendment to our 2022 Plan, in substantially the form attached to the proxy statement as Annex B, to increase the “evergreen provision” percentage by which the number of reserved shares of Common Stock available for issuance increases each year from 2% of the outstanding shares of Common Stock at December 31 to 5% of the outstanding shares of Common Stock at December 31 (the “2022 Plan Evergreen Increase Proposal” or “Proposal 4”);
5.To approve an adjournment of the Annual Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the 2022 Plan Share Increase Proposal or the 2022 Plan Evergreen Increase Proposal (the “Adjournment Proposal” or “Proposal 5”);
6.To consider and vote upon any other matters that may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2024-05-13 |
详情>>
业绩披露：
2024年一季报每股收益-2.75美元,归母净利润-322.04万美元,同比去年增长-111.8%
|
| 2024-03-01 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2023-12-07 |
股东大会：
将于2023-12-28召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Amendment”), in substantially the form attached to the proxy statement as Annex A, to, at the discretion of the Board of Directors of the Company (the “Board”), effect a reverse stock split with respect to the Company’s issued and outstanding common stock, par value $0.00001 per share (“Common Stock”), including stock held by the Company as treasury shares, at a ratio of 1-for-2 to 1-for-20 (the “Range”), with the ratio within such Range (the “Reverse Stock Split Ratio”) to be determined at the discretion of the Board and included in a public announcement (the “Reverse Stock Split Proposal” or “Proposal 1”);
2.To approve an amendment to our 2022 Equity Incentive Plan (the “2022 Plan”), in substantially the form attached to the proxy statement as Annex B, to increase the number of shares of Common Stock that will be available for awards under the 2022 Plan by 2,300,000 shares to 3,800,000 shares and to increase the “evergreen provision” percentage by which the number of reserved shares of Common Stock available for issuance increases each year from 2% of the outstanding shares of Common Stock at December 31 to 5% of the outstanding shares of Common Stock at December 31 (the “2022 Plan Amendment Proposal” or “Proposal 2”);
3.To approve an adjournment of the 2023 Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Reverse Stock Split Proposal and/or the 2022 Plan Amendment Proposal (the “Adjournment Proposal” or “Proposal 3”).
|
| 2023-12-07 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.91美元,归母净利润-1062.78万美元,同比去年增长43.06%
|
| 2023-08-14 |
详情>>
业绩披露：
2023年中报每股收益-0.4美元,归母净利润-463.33万美元,同比去年增长57.96%
|
| 2023-06-07 |
股东大会：
将于2023-07-24召开股东大会
会议内容 ▼▲
- 1.To elect the three director nominees named herein to serve as Class II directors for a three-year term expiring at the annual meeting of stockholders in 2026;
2.To ratify the appointment of EisnerAmper LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023;
3.To consider and vote upon any other matters that may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2023-05-12 |
详情>>
业绩披露：
2023年一季报每股收益-0.13美元,归母净利润-152.05万美元,同比去年增长70.40%
|
| 2022-11-09 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-1.59美元,归母净利润-1866.36万美元,同比去年增长-135.1%
|
| 2022-06-15 |
股东大会：
将于2022-07-25召开股东大会
会议内容 ▼▲
- 1.To elect two director nominees to serve as Class I directors for a three-year term expiring at the annual meeting of stockholders in 2025;
2.To approve the 2022 Virpax Equity Incentive Plan;
3.To ratify the appointment of EisnerAmper LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022;
4.To consider and vote upon any other matters that may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2022-05-24 |
详情>>
内部人交易：
Sendrow Jerrold股份增加4500.00股
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|